← Back to headlines
Jefferies Initiates 'Buy' Rating for Caris Life Sciences
Jefferies has commenced coverage of Caris Life Sciences Inc. (CAI) with a 'Buy' rating, indicating a favorable investment recommendation.
20 Apr, 21:33 — 20 Apr, 21:33
Sources
Showing 1 of 1 sources
